Clinical Talks: Detect cancer early, while it still can be cured
September 30 @ 17:00 – 17:30 CEST
On September 30, Dr. Hyunsung John Kim, will talk about the amazing potential RNA liquid biopsies can offer modern healthcare, by detecting cancer early, while it still can be cured. Resulting in a total transformation of cancer care, ultimately allowing for a more efficient, cost-effective, and sustainable healthcare. While working as a senior Bioinformatician at Illumina, John was part of the founding team who branched out GRAIL, with its very promising Galleri multi-cancer early detection test soon to hit our Clinical reality.
John develops cloud computing tools that use machine learning and AI to generate biological insights from large clinically relevant datasets. He has worked in Next Generation Sequencing (NGS) and bioinformatics for over ten years in academic and industrial settings.
He started his career at the University of California at Santa Cruz where he received the Chancellor’s fellowship for designing new sequencing assays and algorithms for diagnostics and immunology. After receiving his PhD in Bioinformatics and Biomolecular Engineering, John joined the Advanced Research group at Illumina. There he played a critical role in launching Illumina’s single cell product by developing the accompanying cloud-based bioinformatics software and was given the CEO award for his contributions.
John departed from Illumina to make a significant impact on the fight against cancer by joining GRAIL Inc. as one of its founding members. At GRAIL, he led a team of data scientists, software engineers and statisticians as a bioinformatics technical lead. His team worked to gain a better understanding cell free nucleic acids and develop diagnostic products that detect cancer earlier than the current standard of care. John holds multiple patents and was an author on the first patent awarded to GRAIL. In addition, he has co-authored peer-reviewed publications on his work related to the early cancer detection from cell free nucleic acids.
Clinical Talks Series
After our recent planning hiatus, we now have the great pleasure to announce that “Clinical Talks” has been renewed for yet another exciting, innovative, and enlightening season. This season will focus on sustainable innovations within Life Sciences, that have the potential to contribute to a better climate friendly future for our future generations. Also new this year is that the seminar is co-organized in a collaboration between SciLifeLab and KI Innovations.
Season 5, will be held September until December 2021 with a total of seven scheduled Talks, during Friday mornings 09-09:30 am via ZOOM (with some time-zone friendly adjustments for our international speakers). Each session consists of a talk given by our invited speaker followed by Q&A. The seminar is an open educational seminar series for our ever-expanding Life Science community.